TABLE 1.
Expressed siRNA or genes | Mean abnormalities/ cell (SD)a
|
% of cells with abnormalities (SD) | P valuec | |
---|---|---|---|---|
Fusionb | Breaks | |||
Control | 0 | 0.03 (0.05) | 3 (5) | |
siPOT1-A | 0.04 (0.06) | 0.29 (0.18) | 25 (16) | 0.06 |
siPOT1-B | 0.02 (0.02) | 0.20 (0.1) | 20 (9) | 0.03 |
POT1-sh1 | 0.10 (0.08) | 0.30 (0.1) | 30 (12) | 0.03 |
POT1-sh2 | 0.08 (0.06) | 0.30 (0.1) | 28 (9) | 0.03 |
TRF2ΔBΔM | 0.40 (0.15) | 0.62 (0.66) | 43 (31)d | 0.02 |
TRF2ΔBΔM+POT1 | 0 | 0.17 (0.07) | 17 (7) | 0.05 |
POT1 | 0 | 0.04 (0.01) | 4 (1) | 1.0 |
The numbers indicated average abnormalities per metaphase cell from four independent experiments; a total of 100 cells were scored.
Chromosome fusion contained multicentric chromosomes and chromosome end joining.
Frequencies of percent of cells with abnormalities were compared with the control group.
Frequency was higher than the TRF2ΔBΔM + POT1 group with a P value of 0.08.